title: Preemptive therapy with plasmapheresis/intravenous immunoglobulin allows successful live donor renal transplantation in patients with a positive cross-match.
authors.affiliation: Department of Surgery, Johns Hopkins University School of Medicine, 720 Rutland Avenue, Baltimore, MD 21205, USA.
authors.forename: C J
authors.initials: CJ
authors.lastname: Sonnenday
authors.forename: L E
authors.initials: LE
authors.lastname: Ratner
authors.forename: A A
authors.initials: AA
authors.lastname: Zachary
authors.forename: J F
authors.initials: JF
authors.lastname: Burdick
authors.forename: M D
authors.initials: MD
authors.lastname: Samaniego
authors.forename: E
authors.initials: E
authors.lastname: Kraus
authors.forename: D S
authors.initials: DS
authors.lastname: Warren
authors.forename: R A
authors.initials: RA
authors.lastname: Montgomery
mesh_terms: D000328:Adult; D000368:Aged; D003131:Combined Modality Therapy; D003404:Creatinine / Q000097:blood; D005260:Female; D005500:Follow-Up Studies; D006650:Histocompatibility Testing; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D007518:Isoantibodies / Q000097:blood; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D019520:Living Donors; D008297:Male; D008875:Middle Aged; D010956:Plasmapheresis; D044469:Racial Groups; D012189:Retrospective Studies; D016559:Tacrolimus / Q000627:therapeutic use; D013997:Time Factors; D014481:United States
chemical_list: D016756:Immunoglobulins, Intravenous; D007518:Isoantibodies; D003404:Creatinine; D016559:Tacrolimus